HCA Healthcare (NYSE:HCA) Price Target Increased to $359.00 by Analysts at Deutsche Bank Aktiengesellschaft

HCA Healthcare (NYSE:HCAFree Report) had its target price raised by Deutsche Bank Aktiengesellschaft from $330.00 to $359.00 in a report published on Friday morning, Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock.

A number of other equities analysts also recently issued reports on the stock. Oppenheimer reissued an outperform rating and issued a $315.00 price target on shares of HCA Healthcare in a research note on Wednesday, January 17th. StockNews.com downgraded shares of HCA Healthcare from a strong-buy rating to a buy rating in a research note on Thursday, February 15th. Barclays initiated coverage on shares of HCA Healthcare in a report on Wednesday, March 6th. They issued an overweight rating and a $356.00 price objective on the stock. Truist Financial upped their price objective on shares of HCA Healthcare from $320.00 to $345.00 and gave the stock a buy rating in a report on Wednesday, January 31st. Finally, Wells Fargo & Company upped their price objective on shares of HCA Healthcare from $303.00 to $315.00 and gave the stock an equal weight rating in a report on Thursday, March 28th. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of Moderate Buy and an average price target of $314.05.

Get Our Latest Research Report on HCA Healthcare

HCA Healthcare Stock Performance

NYSE HCA opened at $322.82 on Friday. HCA Healthcare has a 52-week low of $215.96 and a 52-week high of $335.83. The company has a debt-to-equity ratio of 35.07, a quick ratio of 1.02 and a current ratio of 1.18. The company has a market capitalization of $85.38 billion, a P/E ratio of 17.01, a P/E/G ratio of 1.62 and a beta of 1.65. The company has a fifty day moving average of $319.77 and a 200-day moving average of $279.63.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings data on Tuesday, January 30th. The company reported $5.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.05 by $0.85. HCA Healthcare had a net margin of 8.07% and a return on equity of 996.30%. The company had revenue of $17.30 billion during the quarter, compared to the consensus estimate of $16.51 billion. During the same period in the previous year, the firm posted $4.64 EPS. The firm’s revenue was up 11.7% compared to the same quarter last year. As a group, equities research analysts predict that HCA Healthcare will post 20.49 EPS for the current fiscal year.

HCA Healthcare declared that its Board of Directors has authorized a share buyback plan on Tuesday, January 30th that authorizes the company to buyback $6.00 billion in outstanding shares. This buyback authorization authorizes the company to buy up to 7.4% of its stock through open market purchases. Stock buyback plans are usually an indication that the company’s leadership believes its shares are undervalued.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 29th. Investors of record on Friday, March 15th were given a dividend of $0.66 per share. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.60. The ex-dividend date was Thursday, March 14th. This represents a $2.64 dividend on an annualized basis and a yield of 0.82%. HCA Healthcare’s dividend payout ratio is 13.91%.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Chad J. Wasserman sold 876 shares of the stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $330.25, for a total value of $289,299.00. Following the transaction, the senior vice president now directly owns 1,576 shares in the company, valued at $520,474. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other HCA Healthcare news, SVP Chad J. Wasserman sold 876 shares of the stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $330.25, for a total value of $289,299.00. Following the transaction, the senior vice president now directly owns 1,576 shares in the company, valued at $520,474. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Michael S. Cuffe sold 3,200 shares of the stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $306.79, for a total transaction of $981,728.00. Following the completion of the transaction, the executive vice president now owns 24,929 shares in the company, valued at $7,647,967.91. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 14,840 shares of company stock worth $4,588,869. Company insiders own 1.60% of the company’s stock.

Institutional Trading of HCA Healthcare

Several institutional investors and hedge funds have recently modified their holdings of the company. Parkside Financial Bank & Trust grew its stake in HCA Healthcare by 8.2% during the fourth quarter. Parkside Financial Bank & Trust now owns 461 shares of the company’s stock valued at $125,000 after acquiring an additional 35 shares in the last quarter. FinTrust Capital Advisors LLC grew its stake in HCA Healthcare by 26.7% during the fourth quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock valued at $45,000 after acquiring an additional 35 shares in the last quarter. Ballentine Partners LLC grew its stake in HCA Healthcare by 1.0% during the first quarter. Ballentine Partners LLC now owns 3,879 shares of the company’s stock valued at $1,294,000 after acquiring an additional 38 shares in the last quarter. Wedmont Private Capital grew its stake in HCA Healthcare by 1.6% during the fourth quarter. Wedmont Private Capital now owns 2,527 shares of the company’s stock valued at $711,000 after acquiring an additional 39 shares in the last quarter. Finally, Valley Wealth Managers Inc. grew its stake in HCA Healthcare by 4.1% during the fourth quarter. Valley Wealth Managers Inc. now owns 981 shares of the company’s stock valued at $266,000 after acquiring an additional 39 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Company Profile

(Get Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Stories

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.